Phase II Study - Trial of a Phototherapy Light Device to Improve Sleep Health

University of Arizona30 enrolled

Overview

There are few devices currently on the market claiming to improve sleep. This study will investigate the efficacy of phototherapy on improving sleep, in the form of a wearable neck device used at night.

This study will investigate the efficacy of phototherapy on improving sleep, in the form of a wearable neck device used at night. Phototherapy has been shown to improve chronic pain, cerebral blood flow, neurological function, and capillary growth in skeletal muscle. A device worn at night may improve sleep onset, total sleep time, or modify sleep architecture. Improved cardiovascular function may facilitate a decrease in core body temperature needed for sleep onset. Relaxation from direct heat may help to decrease cortisol levels, thus reducing the number of night-time arousals. It may also decrease circulating levels of norepinephrine (NE), one of the main neurotransmitters involved in arousal. The aim of this study is to evaluate if the device worn leads to greater next-day wellbeing and cognitive function as a result of increased slow-wave activity.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Sleep

Interventions

Phototherapy deviceDEVICE

The active phototherapy device will emit light

Eligibility

Sex: ALLMin age: 30 YearsMax age: 60 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: 1. Between the ages of 18 and 60 years old 2. Able to read and write fluently in English 3. Access to a mobile device for video calls, online questionnaires, syncing devices, and communication with study staff 4. Access to a residential mailing address for shipping study materials 5. Exhibit a score of \>8 on the Insomnia Severity Index 6. Self-report that they have a problem with their sleep that they wish to improve Exclusion Criteria: 1. Have a moderate to severe current sleep disorder 2. Have a current psychiatric disorder 3. Are taking medication that would interfere with sleep, including beta blockers, antidepressants, antianxiety medications, hypnotics, or stimulants 4. Have a medical condition that would interfere with their ability to complete all study procedures or would render measurements invalid (e.g., some autoimmune conditions, cardiac conditions, endocrine conditions, or chronic pain conditions) 5. Exhibit a regular sleep schedule, where bed and wake times are kept within a 2-hour window 7 days per week 6. Exhibit a regular sleep schedule during the night, beginning no earlier than 9pm and ending no later than 10am 7. Have not engaged in shift work for the past month, and will refrain from shift work during the study 8. Are unable to restrict alcohol consumption to no more than 2 drinks within 4 hours of sleep 9. Are unable to restrict caffeine use to no coffee or caffeinated beverages after 12pm during the study 10. Regularly smoke or use other tobacco products 11. Regularly use cannabis-derived medicinal products 12. Are pregnant 13. Are a full-time caregiver to an individual that requires attending during the evening and night

Locations (1)

Department of Psychiatry, University of Arizona

Tucson, Arizona, United States

RECRUITING

Outcomes

Primary Outcomes

Change in subjective rating of the device across a 3-week intervention

There will be a subjective rating of the phototherapy device using a series of questions assessing device's effect on sleep and next-day function at the end of the trial.

Time frame: Change in subjective rating of the device from baseline (pre; Day 0) to after 21 days of wearing it (post)

Change in Insomnia Severity Index (ISI) scores across a 3-week intervention

The ISI is a 7-item insomnia screening tool that is the gold standard for quantifying severity of clinical insomnia symptoms.

Time frame: Change from baseline over the course of the study (after 21 days of wearing the device)

Change in objective sleep efficiency across a 3-week intervention

Objective sleep efficiency will be measured with a wearable device (Oura ring) that is worn for the duration of the study and captures sleep and wake data using actigraphy.

Time frame: Change from mean baseline period (first two weeks of wear) to post three weeks of wearing the phototherapy device.

Secondary Outcomes

Change in mean sleep latency assessed using sleep diaries

Sleep latency, or time taken to fall asleep, will be assessed using morning sleep diaries completed by the participant upon awakening. The mean sleep latency during the baseline period (pre) will be compared to after three weeks of wearing the phototherapy device (post).

Time frame: Change from mean baseline period (first two weeks of wear) to post three weeks of wearing the phototherapy device.

Change in Karolinska Sleepiness Scale (KSS) score

The Karolinska Sleepiness Scale (KSS) measures situational sleepiness on a 9-point scale

Time frame: Change from before intervention (pre) to post three weeks of wearing the phototherapy device (Day 21)..

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Circadian Energy Scale (CIRENS) score

CIRENS is a very short and simple chronotype measurement tool based on energy. The CIRENS consists of two introspective questions about the usual energy level (very low, low, moderate, high, or very high, scored 1 to 5) in the morning and in the evening. The difference between energy level scores (-4 to 4) felt by respondents in the evening and morning defines the chronotype score and classification.

Time frame: Change from baseline (pre) to post three weeks of wearing the phototherapy device (Day 21).

Positive and Negative Affect Scales (PANAS) Positive Affect

The Positive and Negative Affect Scales are brief screening measures that assess both positive and negative emotional experiences. This scale will allow for separate assessment of impact on positive mood.

Time frame: Change from baseline (pre) to post three weeks of wearing the phototherapy device (Day 21).

Positive and Negative Affect Scales (PANAS) Negative Affect

Time frame: Change from baseline (pre) to post three weeks of wearing the phototherapy device (Day 21).

Change in Fatigue Severity Scale (FSS) across a three-week intervention

Fatigue Severity Scale (FSS) is a well-validated 9-item clinical measure that assesses overall levels of mental and physical fatigue, with answers ranging from 1- "Strongly Disagree" to 7-"Strongly Agree".

Time frame: Change from baseline (pre) to post three weeks of wearing the phototherapy device (Day 21).

Change in Profile of Mood States (POMS) across a three week intervention

The Profile of Mood States (POMS) is a psychological rating scale used to assess transient, distinct mood states. The POMS measures six different dimensions of mood swings over a period of time. These include: Tension or Anxiety, Anger or Hostility, Vigor or Activity, Fatigue or Inertia, Depression or Dejection, Confusion or Bewilderment. A total score will be evaluated in addition to the individual items.

Time frame: Change from baseline (pre) to post three weeks of wearing the phototherapy device (Day 21).

Change in Wake After Sleep Onset (WASO) assessed using morning sleep diaries over the duration of the study

Wake after sleep onset (WASO), or the number of nocturnal awakenings, will be assessed using morning sleep diaries completed by the participant upon awakening. The mean WASO during the baseline period (pre) will be compared to after three weeks of wearing the phototherapy device (post).

Time frame: Change from mean baseline period (first two weeks of wear) to post three weeks of wearing the phototherapy device.

Change in sleep efficiency assessed using morning sleep diaries over the duration of the study

Sleep efficiency, or the amount of time spent asleep during a sleep opportunity, will be assessed using morning sleep diaries completed by the participant upon awakening. The mean sleep efficiency during the baseline period (pre) will be compared to after three weeks of wearing the phototherapy device (post).

Time frame: Change from mean baseline period (first two weeks of wear) to post three weeks of wearing the phototherapy device.

Change in total sleep time assessed using morning sleep diaries over the duration of the study

Total sleep time will be assessed using morning sleep diaries completed by the participant upon awakening. The mean total sleep time during the baseline period (pre) will be compared to after three weeks of wearing the phototherapy device (post).

Time frame: Change from mean baseline period (first two weeks of wear) to post three weeks of wearing the phototherapy device.

Change in morning refreshed feeling assessed using morning sleep diaries over the duration of the study

Morning refreshed feeling will be assessed using morning sleep diaries completed by the participant upon awakening. The mean refreshed feeling during the baseline period (pre) will be compared to after three weeks of wearing the phototherapy device (post).

Time frame: Change from mean baseline period (first two weeks of wear) to post three weeks of wearing the phototherapy device.